Ocuphire Pharma, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Equipment, Net

Equipment, Net

6 Months Ended

Jun. 30, 2012

6. Equipment, Net

	June 30,	December 31,
	2012	2011

Furniture and fixtures	$ 34,200	$ 34,200
Office equipment	81,074	81,074
Lab and computer equipment	430,261	430,261
Leasehold improvements	119,841	119,841

Total fixed assets	665,376	665,376
Less: Accumulated depreciation	(592,276)	(570,834)

Net carrying amount	$ 73,100	$ 94,542

Depreciation expense was $10,721 and $10,650 for the three months ended June 30, 2012 and 2011, respectively, and $21,442, and $24,777 for the six months ended June 30, 2012 and 2011, respectively.

- Definition

The entire disclosure for long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software. This disclosure may include property plant and equipment accounting policies and methodology, a schedule of property, plant and equipment gross, additions, deletions, transfers and other changes, depreciation, depletion and amortization expense, net, accumulated depreciation, depletion and amortization expense and useful lives, income statement disclosures, assets held for sale and public utility disclosures.

+ References + Details